Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Onconova Therapeutic
(NQ:
ONTX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 2, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Onconova Therapeutic
< Previous
1
2
3
4
5
6
Next >
Onconova Therapeutics Announces Dosing of First Participant in Investigator-Sponsored Phase 2 Trial of Rigosertib Plus Pembrolizumab in Metastatic Melanoma Patients Refractory to Immune Checkpoint Blockade
May 25, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics: Q1 Earnings Insights
May 15, 2023
Via
Benzinga
Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update
May 15, 2023
Conference call and live webcast at 4:30 p.m. ET today
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Earnings Outlook For Onconova Therapeutics
May 12, 2023
Via
Benzinga
Preview: Onconova Therapeutics's Earnings
March 15, 2023
Via
Benzinga
Onconova Therapeutics to Participate in Ladenburg Thalmann Virtual R&D Showcase on Narazaciclib in Endometrial Cancer
May 12, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics Doses First Patient in Phase 1/2a Trial of Narazaciclib Combined with Letrozole in Endometrial Cancer
May 11, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics to Present at the ISID International Epidermolysis Bullosa Symposium
May 08, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics to Provide Corporate Update and Announce First Quarter 2023 Financial Results on May 15, 2023
May 04, 2023
Company to host conference call and webcast at 4:30 p.m. ET on Monday, May 15, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 24, 2023
Via
Benzinga
Nasdaq Edges Higher; Procter & Gamble Posts Upbeat Earnings
April 21, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite edging higher on Friday. The Dow traded down 0.06% to 33,765.47 while the NASDAQ rose 0.02% to 12,062.18. The S&P 500, also...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
April 21, 2023
Via
Benzinga
Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
April 21, 2023
Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.
Via
Benzinga
Gold Down Over 1%; US Composite PMI Rises In April
April 21, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 70 points on Friday. The Dow traded down 0.20% to 33,718.74 while the NASDAQ fell 0.33% to 12,019.40. The S&P 500,...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 21, 2023
April 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 21, 2023
Via
Benzinga
Onconova Therapeutics Announces the Presentation of New Preclinical Data on Narazaciclib at the AACR Annual Meeting
April 19, 2023
Data further characterize narazaciclib’s mechanism of action and show its anti-cancer activity comparing favorably to that of FDA-approved CDK 4/6 inhibitors
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics Announces the Unexpected Passing of Chief Medical Officer Dr. Mark Gelder
April 06, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics and Pangea Biomed Enter into Research Collaboration to Identify Biomarkers of Response to Rigosertib
March 23, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics Reports Full Year 2022 Financial Results and Provides Business Update
March 16, 2023
Conference call and live webcast at 4:30 p.m. ET today
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics Announces Upcoming Poster Presentations at the AACR Annual Meeting
March 15, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics to Provide Corporate Update and Announce Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023
March 09, 2023
Company to host conference call and webcast at 4:30 p.m. ET on Thursday, March 16, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics Presents Preclinical Data Characterizing Rigosertib’s Mechanisms of Action at the AACR Targeting RAS Conference
March 07, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 07, 2023
Via
Benzinga
Onconova Therapeutics Touts Additional Positive Data For Rigosertib Monotherapy In Skin Cancer Setting
February 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 07, 2023
Via
Benzinga
Onconova Therapeutics Announces Additional Clinical Data Demonstrating Rigosertib’s Monotherapy Activity in RDEB-Associated Squamous Cell Carcinoma
February 07, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
Onconova Therapeutics to Present at the 2023 Guggenheim Oncology Conference
February 01, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
January 30, 2023
Via
Benzinga
Onconova Therapeutics Announces Participation in the Channelchek Takeaway Series
January 26, 2023
From
Onconova Therapeutics, Inc.
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.